Pelthos Therapeutics posts corporate presentation; no specific material updates disclosed

Pelthos Therapeutics Inc.

Corporate presentation for Q4 2025 made available on company website on October 14, 2025.
No financial results, guidance, or product-specific updates provided in the filing text.
The exhibit text is truncated, precluding identification of any material developments.
Presentation furnished under Regulation FD and not incorporated by reference into SEC filings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.